Boy, given the statements in the link, wonder now,
Post# of 157823
$4.1 Billion investment to expand its manufacturing capacity in Clayton, North Carolina
CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC Laboratories
Quote:
" The results of these three preclinical studies support both the biologic activity and potential clinical benefit of leronlimab’s ability to bind to CCR5 receptors on hepatic stellate cells, leading to a reversal of established liver fibrosis,” said Melissa Palmer, MD FAASLD, the Company’s Lead Consultant in Hepatology ."

